logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

WCLC 2019 – Tissue tumour mutational burden does not predict response to chemoimmunotherapy in advanced nonsquamous NSCLC

New KEYNOTE-021 and KEYNOTE-189 data shows no association of tissue tumour mutational burden with clinical outcomes of pembrolizumab plus chemotherapy